Production R & D
Product Search
R&D institute is responsible for new products research and regulatory filings. With 6-10% of annual sales revenue, the company focuses on cardiovascular and cerebrovascular medications for chronic diseases. Our products range has expanded significantly, currently more than twenty projects establishment approved and more than ten production approval licenses will be obtained. And five new products research to be launched every year.
Since its establishment, the institute has pursued both independent R&D and outsourced R&D simultaneously. It has successfully established complementary R&D partnerships with over a dozen research institutions and universities, including the Chemical Institute of Hunan University, the Chemical Institute of Central South University, Institue of Materia Medica Chinese Academy of Medical Science, and the Hunan Provincial Laboratory Animal Center/Hunan Drug Safety Evaluation Research Center. The institute has also established collaborations with research organizations, such as Beijing Sunnovo Pharmaceutical Research Co., Ltd., Beijing Nuokangda Pharmaceutical Technology Co., Ltd., Hunan Huize Biopharma Technology Co., Ltd., and Nanjing Shuangke Pharmacy Co. Ltd.
Through years of accumulation, the R&D institute has delivered the satisfactory achievement to the company, With the continuous approval of new products, it will provide new power for company’s sustainable development.
Contact Information
Manufacturing base address: No.97
Kangping Road, Economic Development Zone, Liuyang
Office address in Changsha: Floor 8, business building, Mawangdui Science and Technology Park, No. 948, Yuanda First Road, Changsha
1
